Precision for Medicine, Inc.
Precision for Medicine, Inc., headquartered in the United States, is a leading provider of precision medicine solutions, specialising in the integration of advanced technologies and data analytics to enhance drug development and patient care. Founded in 2015, the company has rapidly established itself in the biopharmaceutical industry, focusing on areas such as genomics, biomarker discovery, and clinical trial optimisation. With a commitment to delivering tailored solutions, Precision for Medicine offers unique services that include laboratory testing, clinical trial management, and regulatory support, all designed to accelerate the path to market for innovative therapies. The company’s strategic approach and expertise have positioned it as a trusted partner for pharmaceutical and biotechnology firms, contributing to significant advancements in personalised medicine.
DitchCarbon Score
How does Precision for Medicine, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Precision for Medicine, Inc.'s score of 25 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Precision for Medicine, Inc.'s reported carbon emissions
Precision for Medicine, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Precision Medicine Group, LLC, which may influence its climate commitments and reporting practices. As of now, there are no documented reduction targets or climate pledges from Precision for Medicine, Inc. However, it is important to note that the company may align its sustainability efforts with those of its parent organisation, Precision Medicine Group, LLC, which operates at a higher cascade level. This relationship suggests that any climate initiatives or targets may be inherited from the parent company, although specific details on these initiatives are not provided. In the broader context of the industry, many organisations are increasingly focusing on reducing their carbon footprints and committing to science-based targets. Precision for Medicine, Inc. may consider adopting similar strategies in the future to enhance its environmental sustainability and align with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Precision for Medicine, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
